A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogeneic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR)
Clinical trial NCT04608838 · COMPLETED
Trial details
- NCT number
- NCT04608838
- Sponsor
- Teijin Pharma Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2021-02-15
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.